125 related articles for article (PubMed ID: 8347731)
1. Ubenimex in the treatment of acute nonlymphocytic leukemia in adults.
Urabe A; Mutoh Y; Mizoguchi H; Takaku F; Ogawa N
Ann Hematol; 1993 Aug; 67(2):63-6. PubMed ID: 8347731
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled study of chemoimmunotherapy with bestatin of acute nonlymphocytic leukemia in adults.
Ota K; Ogawa N
Biomed Pharmacother; 1990; 44(2):93-101. PubMed ID: 2224060
[TBL] [Abstract][Full Text] [Related]
3. Review of ubenimex (Bestatin): clinical research.
Ota K
Biomed Pharmacother; 1991; 45(2-3):55-60. PubMed ID: 1912370
[TBL] [Abstract][Full Text] [Related]
4. Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group.
Kobayashi T; Miyawaki S; Tanimoto M; Kuriyama K; Murakami H; Yoshida M; Minami S; Minato K; Tsubaki K; Ohmoto E; Oh H; Jinnai I; Sakamaki H; Hiraoka A; Kanamaru A; Takahashi I; Saito K; Naoe T; Yamada O; Asou N; Kageyama S; Emi N; Matsuoka A; Tomonaga M; Ohno R
J Clin Oncol; 1996 Jan; 14(1):204-13. PubMed ID: 8558199
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of chronic adult T-cell leukemia with ubenimex.
Okamura T; Shibuya T; Harada M; Niho Y
Acta Haematol; 1992; 87(1-2):94-7. PubMed ID: 1350160
[TBL] [Abstract][Full Text] [Related]
6. [Results of follow-up studies on prognosis after immunotherapy with bestatin in acute nonlymphocytic leukemia].
Ota K; Kurita S; Yamada K; Masaoka T; Uzuka Y; Ogawa N
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1017-25. PubMed ID: 3963846
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy with ubenimex corresponding to patient age and organ disorder for 18 cases of acute myelogeneous leukemia in elderly patients--effects, complications and long-term survival].
Hirayama Y; Sakamaki S; Takayanagi N; Tsuji Y; Sagawa T; Chiba H; Matsunaga T; Niitsu Y
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1113-8. PubMed ID: 12938265
[TBL] [Abstract][Full Text] [Related]
8. [Double blind controlled study of ubenimex (Bestatin) against squamous cell lung cancer--a multicenter cooperative study].
Furuse K; Fukuoka M; Genka K; Kato H; Tsubura E; Ohta M; Nakai H; Kinuwaki E; Nakano M; Ishikawa S
Gan To Kagaku Ryoho; 1993 Jul; 20(9):1187-94. PubMed ID: 8333747
[TBL] [Abstract][Full Text] [Related]
9. [A case of renal cell carcinoma with lymph node metastasis keeping remission for five years by adjuvant immunotherapy with ubenimex].
Sugano O; Muto A; Kato M; Ono K
Gan To Kagaku Ryoho; 2003 Oct; 30(10):1519-22. PubMed ID: 14584289
[TBL] [Abstract][Full Text] [Related]
10. Long-term cytogenetic remission with ubenimex monotherapy in a case of chronic myeloid leukemia.
Kanamori H; Takasaki H; Takabayashi M; Yamaji S; Koharazawa H; Fujimaki K; Taguchi J; Ishigatsubo Y
Anticancer Drugs; 2004 Aug; 15(7):729-31. PubMed ID: 15269606
[TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy with bestatin for acute non-lymphocytic leukemia (ANLL) in adults].
Kurita S; Ota K; Yamada K; Massaoka T; Uzuka Y; Ogawa N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2742-50. PubMed ID: 6508324
[TBL] [Abstract][Full Text] [Related]
12. [Hematological stability under ubenimex monotherapy in a patient with acute myelogenous leukemia developing marrow karyotypic changes during the course].
Shimosegawa K; Ono Y; Sugawara T; Numaoka H; Oikawa H; Ito S; Utsugisawa T; Murai K; Narigasawa Y; Miyairi Y
Rinsho Ketsueki; 1995 Nov; 36(11):1289-94. PubMed ID: 8691570
[TBL] [Abstract][Full Text] [Related]
13. Clinical trials of bestatin for leukemia and solid tumors.
Ota K; Uzuka Y
Biotherapy; 1992; 4(3):205-14. PubMed ID: 1599804
[TBL] [Abstract][Full Text] [Related]
14. [Individualized chemotherapy of adult acute nonlymphocytic leukemia].
Uzuka Y; Saito Y
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1473-80. PubMed ID: 2389943
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy with bestatin for acute nonlymphocytic leukemia in adults.
Ota K; Kurita S; Yamada K; Masaoka T; Uzuka Y; Ogawa N
Cancer Immunol Immunother; 1986; 23(1):5-10. PubMed ID: 3533256
[TBL] [Abstract][Full Text] [Related]
16. [A new antitumor drug with immunomodulating activity, ubenimex (bestatin)].
Tsukagoshi S
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2385-91. PubMed ID: 3496857
[TBL] [Abstract][Full Text] [Related]
17. Effects of ubenimex, a biological response modifier, on myelodysplastic syndrome and chronic leukemia.
Tatsumi N; Sannomiya Y; Sasaki A; Im T; Ota K; Oohira H; Nakao H; Yasui Y
Biomed Pharmacother; 1991; 45(2-3):95-103. PubMed ID: 1912374
[TBL] [Abstract][Full Text] [Related]
18. The effect of ubenimex on N-methyl-N'-nitro-N-nitrosoguanidine-induced stomach tumor in rats.
Ebihara K; Abe F; Yamashita T; Shibuya K; Hayashi E; Takahashi K; Horinishi H; Enomoto M; Ishizuka M; Umezawa H
J Antibiot (Tokyo); 1986 Jul; 39(7):966-70. PubMed ID: 3759651
[TBL] [Abstract][Full Text] [Related]
19. High-dose cytosine arabinoside as consolidation chemotherapy for acute nonlymphocytic leukemia in remission.
Urabe A; Mizoguchi H; Hoshino S; Nomura T; Dan K; Toyama K; Kimura M; Ogawa T; Yamaguchi H; Mutoh Y
Int J Hematol; 1991 Feb; 54(1):75-7. PubMed ID: 1954354
[TBL] [Abstract][Full Text] [Related]
20. 15th International Cancer Congress. Proceedings of the satellite symposium on recent advances of Bestatin (ubenimex), Hamburg, August 19, 1990.
Biomed Pharmacother; 1991; 45(2-3):49-124. PubMed ID: 1680478
[No Abstract] [Full Text] [Related]
[Next] [New Search]
